Plasma insulin and C-peptide concentrations in diabetic patients undergoing hemodialysis: Comparison with five types of high-flux dialyzer membranes

Diabetes Research and Clinical Practice

Volumn 82, Issue 1, 2008, Pages

  Abe, Masanori ^a   Okada, Kazuyoshi ^a   Matsumoto, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

C peptide; Diabetes; Dialyzer; Hemodialysis; Insulin

Indexed keywords

C PEPTIDE; CELLULOSE TRIACETATE; ORAL ANTIDIABETIC AGENT; POLY(METHYL METHACRYLATE); POLYESTER; POLYETHERSULFONE; POLYMER;

ADULT; AGED; ANURIA; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSATE; DIET THERAPY; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HEMODIALYSIS; HUMAN; INSULIN BLOOD LEVEL; KIDNEY CLEARANCE; MALE; PROTEIN BLOOD LEVEL;

AGED; C-PEPTIDE; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 52949098327     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.07.020     Document Type: Article

References (7)

1. Unruh M., Benz R., Greene T., Yan G., Beddhu S., DeVita M., et al. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int. 66 (2004) 355-366
2. Seres D.S., Strain G.W., Hashim S.A., Goldberg I.J., and Levin N.W. Improvement of plasma lipoprotein profiles during high-flux dialysis. J. Am. Soc. Nephrol. 3 (1993) 1409-1415
3. Blankestijin P.J., Vos P.F., Rabelink T.J., van Rijin H.J., Jansen H., and Koomans H.A. High-flux dialysis membranes improve lipid profile in chronic hemodialysis patients. J. Am. Soc. Nephrol. 5 (1995) 1703-1708
4. Wanner C., Bahner U., Mattern R., Lang D., and Passlick-Deetjen J. Effect of dialysis flux and membrane material on dyslipidemia and inflammation in hemodialysis patients. Nephrol. Dial. Transpl. 19 (2004) 2570-2575
5. Schmitz O. Glucose metabolism in non-diabetic and insulin dependent diabetic subjects with end stage renal failure. Dan. Med. Bull. 38 (1991) 32-56
6. Mak R.H., and Wong J.H. The vitamin D/parathyroid hormone axis in the pathogenesis of hypertension and insulin resistance in uremia. Miner. Electro. Metab. 18 (1992) 156-159
7. Mak R.H. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am. J. Physiol. 270 (1996) 839-844